Processing

Please wait...

Settings

Settings

1. EP2361645 - USE OF A CARRIER FOR REMOVAL AMYLOID BETA PROTEIN FROM EXTRACORPOREAL FLUIDS

Office European Patent Office
Application Number 09834392
Application Date 21.12.2009
Publication Number 2361645
Publication Date 31.08.2011
Publication Kind B1
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
M
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
1
Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
36
Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
12
Materials from mammals or birds
14
Blood
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
M
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
1
Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
02
Blood transfusion apparatus
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
M
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
1
Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
14
Dialysis systems; Artificial kidneys; Blood oxygenators
16
with membranes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
A61M 1/36
A61K 35/14
A61M 1/02
A61M 1/16
A61P 25/28
G01N 33/68
CPC
A61M 1/3679
G01N 2333/4709
G01N 2800/2821
A61M 1/02
A61M 1/14
A61M 1/3496
Applicants UNIV FUJITA HEALTH
KANEKA CORP
Inventors KITAGUCHI NOBUYA
KAWAGUCHI KAZUNORI
Designated States
Priority Data 2008326174 22.12.2008 JP
2009007051 21.12.2009 JP
Title
(DE) VERWENDUNG EINES TRÄGERS ZUR ENTFERNUNG VON AMYLOID-BETA-PROTEIN AUS EXTRAKORPORALEN FLÜSSIGKEITEN
(EN) USE OF A CARRIER FOR REMOVAL AMYLOID BETA PROTEIN FROM EXTRACORPOREAL FLUIDS
(FR) UTILISATION D'UN SUPPORT POUR L'ELIMINATION DE PROTEINE AMYLOÏDE-BETA A PARTIR DE FLUIDES EXTRACORPORELS
Abstract
(EN)
An object is to provide a material capable of removing A² from a body fluid efficiently and use of the material, which are developed for the purpose of establishing a therapeutic or preventive method for Alzheimer's disease. Provided is an amyloid ² protein remover, containing a carrier made of any one material selected from the group consisting of cellulose, silica, polyvinyl alcohol, and activated carbon, wherein the carrier does not have an alkyl chain on the surface thereof or has an alkyl chain having 1 to 18 carbon atoms on the surface thereof.

(FR)
L'invention porte sur un produit capable d'extraire de manière efficace l'amyloïde β (Aβ) d'un fluide corporel et sur l'utilisation du matériau, développés dans le but d'établir un procédé thérapeutique ou prophylactique pour la maladie d'Alzheimer. L'invention porte spécifiquement sur un extracteur de protéine amyloïde β comprenant un support constitué d'un produit choisi dans le groupe constitué par la cellulose, la silice, l'alcool polyvinylique et le charbon actif et ne comportant pas de chaîne alkyle ou comportant une chaîne alkyle en C1-18 à sa surface.

Other related publications